Pharmacological effects of tolterodine on human isolated urinary bladder

European Journal of Pharmacology

Volumn 368, Issue 2-3, 1999, Pages 223-230

  Yono, Makoto ^a   Yoshida, Masaki ^a   Wada, Yoshihiro ^a   Kikukawa, Hiroaki ^a   Takahashi, Wataru ^a   Inadome, Akito ^a   Seshita, Hiroshi ^a   Ueda, Shoichi ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Antimuscarinic drug; DD 01; Human; Tolterodine; Urinary bladder

Indexed keywords

MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; PNU 200557; TOLTERODINE; UNCLASSIFIED DRUG;

ARTICLE; BLADDER; BLADDER CONTRACTION; BLADDER MUSCLE; CONTROLLED STUDY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IN VITRO STUDY; PRIORITY JOURNAL; SMOOTH MUSCLE; URINE INCONTINENCE;

AGED; BENZHYDRYL COMPOUNDS; BENZILATES; CALCIUM CHLORIDE; CARBACHOL; CRESOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; FEMALE; HUMANS; MALE; MANDELIC ACIDS; MUSCARINIC AGONISTS; MUSCARINIC ANTAGONISTS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PARASYMPATHOLYTICS; PHENYLPROPANOLAMINE; POTASSIUM CHLORIDE; URINARY BLADDER;

EID: 0033018337     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00036-9     Document Type: Article

References (35)

1. Aida Y., Kaneko Y., Kasama T. Effect of oxybutynin hydrochloride on isolated smooth muscles (ileum, urinary bladder and urethra). Folia Pharmacol. Jpn. 87:1986;629-639.
2. Arunlakshana O., Schild H.O. Some quantitative uses of drug antagonists. Br. J. Pharmacol. 14:1959;48-58.
3. 2-receptors into three types. Br. J. Pharmacol. 90:1987;81P. Proc. Suppl.
4. Blaivas J.G., Labib K.B., Michalik S.J., Zayed A.A.H. Failure of bethanechol denervation supersensitivity as a diagnostic aid. J. Urol. 123:1980;199-201.
5. Caulfield M.P., Birdsall N.J.M. International Union of Pharmacology: XVII. Classification of muscarinic acetylcholine receptors. Pharmacol. Rev. 50:1998;279-290.
6. Dörje F., Wess J., Lambrecht G., Tacke R., Mutschler E., Brann M.R. Antagonist binding profiles of five cloned human muscarinic receptor subtypes. J. Pharmacol. Exp. Ther. 256:1991;727-733.
7. 2 receptors of the heart and vasculature. Life Sci. 40:1987;1507-1511.
8. Eglen R.M., Kenny B.A., Michel A.D., Whiting R.L. Muscarinic activity of McN-A-343 and its value in muscarinic receptor classification. Br. J. Pharmacol. 90:1987;693-700.
9. Eglen R.M., Reddy H., Watson N., Challiss R.A.J. Muscarinic acetylcholine receptor subtypes in smooth muscle. Trends Pharmacol. Sci. 15:1994;114-119.
10. Gater P.R., Alabaster V.A., Piper I. Study of muscarinic receptors mediating mucus secretion in cat trachea. Br. J. Pharmacol. 91:1987;498P. Proc. Suppl.
11. Gillberg P.-G., Sundquist S., Nilvebrant L. Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists. Eur. J. Pharmacol. 349:1998;285-292.
12. Haruno A., Yamasaki Y., Miyoshi K., Miyake H., Tsuchiya K., Kosaka M., Nagai M., Iriki M. Effects of propiverine hydrochloride and its metabolites on isolated guinea pig urinary bladder. Folia Pharmacol. Jpn. 94:1989;145-150.
13. Jensen D. Jr. Pharmacological studies of the uninhibited neurogenic bladder. Acta Neurol. Scand. 64:1981;175-195.
14. Kondo S., Morita T. A study of muscarinic cholinergic receptor subtypes in human detrusor muscle using radioligand binding techniques. Jpn. J. Urol. 84:1993;1255-1261.
15. Lambrecht G., Feifel R., Wagner-Röder M., Strohmann C., Zilch H., Tacke R., Waelbroeck M., Christophe J., Boddeke H., Mutschler E. Affinity profiles of hexahydro-sila-difenidol analogues at muscarinic receptor subtypes. Eur. J. Pharmacol. 168:1989;71-80.
16. Luheshi G., Zar A. Purinoceptor desensitization impairs but does not abolish the non-cholinergic motor transmission in rat isolated urinary bladder. Eur. J. Pharmacol. 185:1990;203-208.
17. Micheletti R., Montagna E., Giachetti A. AF-DX 116, a cardioselective muscarinic antagonist. J. Pharmacol. Exp. Ther. 241:1987;628-634.
18. Moore B.A., Gater P.R., Alabaster V.A. Characterization of the muscarinic receptor subtype involved in contraction of bovine tracheal smooth muscle. Br. J. Pharmacol. 95, 797P:1988;. Proc. Suppl.
19. Mutoh S., Latifpour J., Saito M., Weiss R.M. Evidence for the presence of regional differences in the subtype specificity of muscarinic receptors in rabbit lower urinary tract. J. Urol. 157:1997;717-721.
20. Naerger H., Fry C.H., Nilvebrant L. Effect of tolterodine on electrically induced contractions of isolated human detrusor muscle from stable and unstable bladders. Neurourol. Urodyn. 14:1995;524-526.
21. Nilvebrant L., Glas G., Jönsson A., Sparf B. The in vitro pharmacological profile of tolterodine - a new agent for the treatment of urinary urge incontinence. Neurourol. Urodyn. 13:1994;433-435.
22. Nilvebrant L., Stahl M., Andersson K.-E. Interaction of tolterodine with cholinergic muscarinic receptors in human detrusor. Neurourol. Urodyn. 14:1995;523-524.
23. Nilvebrant L., Andersson K.-E., Gillberg P.-G., Stahl M., Sparf B. Tolterodine - a new bladder-selective antimuscarinic agent. Eur. J. Pharmacol. 327:1997;195-207.
24. Nilvebrant L., Gillberg P.-G., Sparf B. Antimuscarinic potency and bladder selectivity of PNU-200577, a major metabolite of tolterodine. Pharmacol. Toxicol. 81:1997;169-172.
25. Nilvebrant L., Hallén B., Larsson G. Tolterodine - a new bladder selective muscarinic receptor antagonist: preclinical pharmacological and clinical data. Life Sci. 60:1997;1129-1136.
26. 2 receptors in bovine tracheal smooth muscle: discrepancies between binding and function. Eur. J. Pharmacol. 153:1988;73-82.
27. Smith T.L., Yamamura H.I. Carbachol stimulation of phosphatidic acid synthesis: competitive inhibition by pirenzepine in synaptosomes from rat cerebral cortex. Biochem. Biophys. Res. Commun. 130:1985;282-285.
28. 1 muscarinic receptor-mediated facilitation of acetylcholine release in the rat urinary bladder. J. Physiol. 480:1994;81-89.
29. Steers, W.D., 1997. Physiology and pharmacology of the bladder and urethra. In: Walsh, P.C., Retik, A.B., Vaughan Jr., E.D., Wein, A.J. (Eds.), Campbell's Urology, 7th edn. Saunders, Philadelphia, PA, pp. 870-915.
30. 3H ] acetylcholine in the rabbit urinary bladder Eur. J. Pharmacol. 281:1995;1-8.
31. Wada Y., Yoshida M., Kitani K., Kikukawa H., Ichinose A., Takahashi W., Gotoh S., Inadome A., Machida J., Ueda S. Comparison of the effects of various anticholinergic drugs on human isolated urinary bladder. Arch. Int. Pharmacodyn. 330:1995;76-89.
32. Wang P., Luthin G.R., Ruggieri M.R. Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins. J. Pharmacol. Exp. Ther. 273:1995;959-966.
33. Yamaguchi O., Shishido K., Tamura K., Ogawa T., Fujimura T. Evaluation of mRNA encoding muscarinic receptor subtypes in human detrusor muscle. Neurourol. Urodyn. 13:1994;464-465.
34. Yoshida M., Nishi K., Machida J., Sakiyama H., Ikeda K., Ueda S. Effects of phorbol ester on lower urinary tract smooth muscles in rabbits. Eur. J. Pharmacol. 222:1992;205-211.
35. Zar M.A., Iravani M.M., Luheshi G.N. Effect of nifedipine on the contractile responses of the isolated rat bladder. J. Urol. 143:1990;835-839.